This CMO appointment has taken longer than anyone has expected.
I wonder whether COVID and the delayed CMO appointment could be linked. For example if the preferred Contract Manufacturing Organisation is Astrazeneca, then it would make sense that things are delayed due to COVID and a lack of manufacturing slots due to vaccine production.
What other reason could there be for the CMO appointment timeline to be blown out more than 6 months...
Ann: Appendix 4E and Annual Report, page-62
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.335M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14158 | 7.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 19000 | 2 |
View Market Depth
| Last trade - 16.12pm 02/08/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable